Barriers to Chimeric Antigen Receptor T-Cell Therapy.

IF 22.5 1区医学 Q1 ONCOLOGY

JAMA Oncology Pub Date : 2025-05-15 DOI:10.1001/jamaoncol.2025.1127

Yannis K Valtis,Kuo-Kai Chin,David Nemirovsky,Sean M Devlin,Meira Yisraeli Salman,Leora Boussi,Briana Cadzin,Carina McLoughlin,Elizabeth Cathcart,Paul Davis,Chelsea Brooklyn,Todd Goldstein,Chris Famulare,Gunjan L Shah,Moneeza Walji,Michael Scordo,Alexander P Boardman,Roni Shouval,Eytan M Stein,Mark B Geyer,Sham Mailankody,M Lia Palomba,Saad Z Usmani,Gilles Salles,Sergio A Giralt,Miguel-Angel Perales,Jae H Park

引用次数: 0

查看原文本刊更多论文

嵌合抗原受体t细胞治疗的障碍。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

JAMA Oncology Medicine-Oncology

自引率

1.80%

发文量

423

期刊介绍： JAMA Oncology is an international peer-reviewed journal that serves as the leading publication for scientists, clinicians, and trainees working in the field of oncology. It is part of the JAMA Network, a collection of peer-reviewed medical and specialty publications.